Equities

Kainos Laboratories Inc

4556:TYO

Kainos Laboratories Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,195.00
  • Today's Change-17.00 / -1.40%
  • Shares traded1.20k
  • 1 Year change+11.58%
  • Beta0.8009
Data delayed at least 20 minutes, as of Nov 15 2024 05:15 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue5,0564,9234,615
OPERATING EXPENSES
Cost of revenue total2,5052,4102,207
Selling, general and admin. expenses, total1,4661,4641,459
Depreciation/amortization716256
Unusual expense(income)118.806.13
Other operating expenses, total0.000.00--
Total operating expense4,2024,1113,873
Operating income854812742
Other, net682217
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes930845767
Provision for income taxes292277255
Net income after taxes638568512
Minority interest------
Net income before extra. Items638568512
Total extraordinary items------
Net income638568512
Inc.avail. to common excl. extra. Items638568512
Inc.avail. to common incl. extra. Items638568512
EPS RECONCILIATION
Basic/primary weighted average shares4.194.174.05
Basic/primary eps excl. extra items152136126
Basic/primary eps incl. extra items152136126
Dilution adjustment------
Diluted weighted average shares4.194.174.05
Diluted eps excl. extra items152136126
Diluted eps incl. extra items152136126
COMMON STOCK DIVIDENDS
DPS - common stock primary issue322525
Gross dividend - common stock142111111
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental6.997.577.59
SUPPLEMENTAL INCOME
Depreciation, supplemental10399110
Total special items7.178.8011
NORMALISED INCOME
Normalized income before taxes937854778
Effect of special items on income taxes2.252.883.58
Income tax excluding impact of special items294280258
Normalized income after tax643574520
Normalized income avail. to common643574520
Basic normalized EPS153138128
Diluted normalized EPS153138128
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.